SCHEMBL23704429

SCHEMBL23704429

O=C(O)Nc1nc(O)c2[nH]nc(F)c2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23718561 0.84 F2 (0.31) —
SCHEMBL23704483 0.81 — —
SCHEMBL23704338 0.81 — —
SCHEMBL23704384 0.74 SLC29A1 (0.42) —
SCHEMBL23703377 0.71 — —
SCHEMBL23704505 0.70 — —
SCHEMBL25144054 0.70 LMNA (0.36) —
SCHEMBL23703901 0.67 PTK2 (0.33) —
SCHEMBL23711611 0.66 F2 (0.31) —
SCHEMBL23711797 0.66 ALDH1A1 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4097104-A1 1H-PYRAZOLO[4,3-D]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS Bristol-Myers Squibb Company (US) 2022-12-07 — — EP disclosed
WO-2021154663-A1 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2021-08-05 — — WO disclosed
Send feedback